Lipum Investor Relations Material
Latest events
Q2 2025
Lipum
Q2 2025
28 Aug, 2025
Q1 2025
24 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lipum
Access all reports
Lipum is a biotechnology company focused on developing novel treatments for chronic inflammatory diseases. Its research targets specific proteins involved in inflammation pathways, with the aim of developing biological drug candidates for autoimmune conditions. The company is headquartered in Umeå, Sweden, and its shares are listed on the Nasdaq First North Growth Market.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
LIPUM
Country
🇸🇪 Sweden